Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...

Samsung Electronics has sharply reduced its memory chip production—by more than 100 billion units in a year—raising eyebrows ...

South Korean drug maker Samsung BioLogics said on Thursday it plans to split its business into contract manufacturing and development companies, to help allay customer concerns about conflicts of ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

Apple maintained its position as the global leader in the wireless headphone market in the first quarter of 2025, achieving ...

This would indicate a 3% decrease in earnings year-over-year and a 2% increase in sales compared to last year's figures of $1 ...

The global true wireless stereo (TWS) market has made a notable comeback in Q1 2025, with shipments rising by 18 percent to ...

Qualcomm's strong performance, diversification efforts, and industry leadership position it as a top semiconductor stock.

CHICAGO, May 20, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs is pleased to announce the launch of the Amplify Samsung U.S. Natural Gas Infrastructure ETF (USNG) in collaboration with Samsung Asset ...

Canalys’ (now part of Omdia) latest research reveals that Southeast Asia’s smartphone market declined by 3% to 22.8 million ...

Qualcomm's margins are under pressure due to competitive handset markets and automotive pricing. Learn why QCOM stock is a ...

SEOUL (Reuters) -Samsung SDI on Monday slashed the pricing of its new share issue by 17% after its stock declined in a broad market sell-off sparked by concerns over potential U.S. tariffs.